<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ESALY
Use symbol ESAIY
$
()


  • Jefferies biotechnology analyst to hold an analyst/industry conference call

    9/20/2023 - 10:51am
  • What You Missed On Wall Street On Friday

    7/7/2023 - 16:10pm
  • What You Missed On Wall Street This Morning

    7/7/2023 - 12:06pm
  • Biogen, Eisai win full FDA approval for Alzheimer's drug Leqembi

    7/6/2023 - 16:47pm
  • FDA converts Biogen Alzheimer's treatment to full approval

    7/6/2023 - 16:45pm
  • What You Missed On Wall Street On Monday

    6/12/2023 - 16:21pm
  • What You Missed On Wall Street This Morning

    6/12/2023 - 12:01pm
  • Eisai, Biogen: FDA panel votes unanimously to confirm benefit of Leqembi

    6/9/2023 - 18:50pm
  • FDA panel votes 6-0 to back Biogen, Eisai's Leqembi

    6/9/2023 - 15:53pm
  • FDA Peripheral/Central Nervous System Drugs Advisory Committee holds meeting

    6/9/2023 - 09:50am
  • FDA Peripheral/Central Nervous System Drugs Advisory Committee holds meeting

    6/9/2023 - 04:55am
  • FDA Peripheral/Central Nervous System Drugs Advisory Committee holds meeting

    6/8/2023 - 15:08pm
  • Eisai submits marketing authorization application for lecanemab in South Korea

    6/8/2023 - 13:18pm
  • FDA posts briefing document ahead of review of Biogen and Eisai's Leqembi

    6/7/2023 - 11:11am
  • Eisai upgraded to Buy from Neutral at Citi

    5/25/2023 - 06:24am
dynamic_feed Breaking News